Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants-Reference-Cited by-同舟云学术

Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants

Published:2022-01 Issue: Volume:75 Page:103761
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Groß Rüdiger^ORCID,Zanoni Michelle,Seidel Alina^ORCID,Conzelmann Carina,Gilg Andrea,Krnavek Daniela,Erdemci-Evin Sümeyye,Mayer Benjamin,Hoffmann Markus^ORCID,Pöhlmann Stefan,Liu Weimin,Hahn Beatrice H.,Beil Alexandra,Kroschel Joris,Jahrsdörfer Bernd,Schrezenmeier Hubert,Kirchhoff Frank,Münch Jan,Müller Janis A.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference56 articles.

1. Pneumonia of unknown cause – China,2020

2. Coronavirus disease 2019 (COVID-19) Situation Report - 75,2020

3. A global database of COVID-19 vaccinations;Mathieu;Nat Hum Behav,2021

4. Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses;Barrett;Nat Med,2021

5. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial;Ewer;Nat Med,2021

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Designing an integrated sustainable-resilient mix-and-match vaccine supply chain network;Annals of Operations Research;2024-08-14

2. Lessons from COVID‐19: Aspects of prevention, therapeutics, and diagnostics against SARS‐CoV‐2 with special focus on JN.1 and XBB sublineages;MedComm – Future Medicine;2024-06

3. Heterologous Booster Immunization Based on Inactivated SARS-CoV-2 Vaccine Enhances Humoral Immunity and Promotes BCR Repertoire Development;Vaccines;2024-01-24

4. Immunogenicity and safety of heterologous versus homologous prime-boost schedules with inactivated and adenoviral vectored SARS-CoV-2 vaccines – A prospective multi-center study;Heliyon;2024-01

5. Evaluation of antibody and T Cell immunity response in different immunization groups of inactive and mRNA COVID-19 vaccines;Diagnostic Microbiology and Infectious Disease;2024-01